Form 8-K - Current report:
SEC Accession No. 0001437749-25-021990
Filing Date
2025-07-02
Accepted
2025-07-02 16:22:55
Documents
22
Period of Report
2025-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250702_8k.htm   iXBRL 8-K 37503
2 EXHIBIT 4.1 ex_835981.htm EX-4.1 109368
3 EXHIBIT 5.1 ex_835982.htm EX-5.1 15200
4 EXHIBIT 10.1 ex_835983.htm EX-10.1 150927
5 EXHIBIT 10.2 ex_835984.htm EX-10.2 209777
6 EXHIBIT 99.1 ex_835986.htm EX-99.1 12862
11 logosm.jpg GRAPHIC 12780
12 w01.jpg GRAPHIC 18751
13 w02.jpg GRAPHIC 3175
14 w03.jpg GRAPHIC 4425
  Complete submission text file 0001437749-25-021990.txt   864016

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20250701.xsd EX-101.SCH 4060
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250701_def.xml EX-101.DEF 13442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250701_lab.xml EX-101.LAB 17669
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250701_pre.xml EX-101.PRE 13419
24 EXTRACTED XBRL INSTANCE DOCUMENT govx20250702_8k_htm.xml XML 4794
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 251101480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)